These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25384664)

  • 41. Long-term evaluation of the antimicrobial susceptibility and microbial profile of subgingival biofilms in individuals with aggressive periodontitis.
    Lourenço TG; Heller D; do Souto RM; Silva-Senem MX; Varela VM; Torres MC; Feres-Filho EJ; Colombo AP
    Braz J Microbiol; 2015 Jun; 46(2):493-500. PubMed ID: 26273264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biofilm architecture.
    Schuster JJ; Markx GH
    Adv Biochem Eng Biotechnol; 2014; 146():77-96. PubMed ID: 24008919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New approaches to the treatment of biofilm-related infections.
    Wilkins M; Hall-Stoodley L; Allan RN; Faust SN
    J Infect; 2014 Nov; 69 Suppl 1():S47-52. PubMed ID: 25240819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
    Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C
    J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbial biofilm development on neonatal enteral feeding tubes.
    Juma NA; Forsythe SJ
    Adv Exp Med Biol; 2015; 830():113-21. PubMed ID: 25366224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The quantity and quality of dissolved organic matter as supplementary carbon source impacts the pesticide-degrading activity of a triple-species bacterial biofilm.
    Horemans B; Vandermaesen J; Breugelmans P; Hofkens J; Smolders E; Springael D
    Appl Microbiol Biotechnol; 2014 Jan; 98(2):931-43. PubMed ID: 23653124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biofilm-based central line-associated bloodstream infections.
    Yousif A; Jamal MA; Raad I
    Adv Exp Med Biol; 2015; 830():157-79. PubMed ID: 25366227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A model of optimal dosing of antibiotic treatment in biofilm.
    Imran M; Smith HL
    Math Biosci Eng; 2014 Jun; 11(3):547-71. PubMed ID: 24506551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbial communities, extracellular proteomics and polysaccharides: A comparative investigation on biofilm and suspended sludge.
    Zhang P; Guo JS; Shen Y; Yan P; Chen YP; Wang H; Yang JX; Fang F; Li C
    Bioresour Technol; 2015 Aug; 190():21-8. PubMed ID: 25919933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipathogenic properties and applications of low-dimensional materials.
    Shaw ZL; Kuriakose S; Cheeseman S; Dickey MD; Genzer J; Christofferson AJ; Crawford RJ; McConville CF; Chapman J; Truong VK; Elbourne A; Walia S
    Nat Commun; 2021 Jun; 12(1):3897. PubMed ID: 34162835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New antibiotic agents and approaches to treat biofilm-associated infections.
    Lynch AS; Abbanat D
    Expert Opin Ther Pat; 2010 Oct; 20(10):1373-87. PubMed ID: 20636186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
    Bedos JP
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):636-8. PubMed ID: 15234734
    [No Abstract]   [Full Text] [Related]  

  • 54. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biofilm-based implant infections in orthopaedics.
    Arciola CR; Campoccia D; Ehrlich GD; Montanaro L
    Adv Exp Med Biol; 2015; 830():29-46. PubMed ID: 25366219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hoisted by their own petard: do microbial enzymes hold the solution to treating and preventing biofilm infections?
    Snarr BD; Howell PL; Sheppard DC
    Future Microbiol; 2018 Mar; 13():395-398. PubMed ID: 29441819
    [No Abstract]   [Full Text] [Related]  

  • 57. Antimicrobial potential of the ionophore monensin on freshwater biofilm bacteria.
    Winkworth CL; Lear G
    Environ Sci Pollut Res Int; 2014 Sep; 21(17):10139-50. PubMed ID: 24809489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concepts in disinfection of bacterial populations.
    Cogan NG
    Math Biosci; 2013 Oct; 245(2):111-25. PubMed ID: 23891584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of inter-species cell-cell co-aggregation between Lactobacillus plantarum ML11-11 and Saccharomyces cerevisiae BY4741 in mixed-species biofilm formation.
    Furukawa S; Nojima N; Yoshida K; Hirayama S; Ogihara H; Morinaga Y
    Biosci Biotechnol Biochem; 2011; 75(8):1430-4. PubMed ID: 21821955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Voice prostheses, microbial colonization and biofilm formation.
    Leonhard M; Schneider-Stickler B
    Adv Exp Med Biol; 2015; 830():123-36. PubMed ID: 25366225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.